Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Genotype 4”

150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 150 results

Not applicableStudy completedNCT02098616
What this trial is testing

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

Who this might be right for
Hepatitis C
Timothy Morgan, MD 25
Post-approval studies (Phase 4)Study completedNCT01429792
What this trial is testing

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,013
Large-scale testing (Phase 3)Study completedNCT02486406
What this trial is testing

Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 64
Large-scale testing (Phase 3)Study completedNCT02247401
What this trial is testing

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Who this might be right for
HCVHepatitis C InfectionGenotype 4
AbbVie 160
Post-approval studies (Phase 4)Study completedNCT00540345
What this trial is testing

Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 300
Large-scale testing (Phase 3)Study completedNCT02483156
What this trial is testing

Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis c
Egyptian Liver Hospital 80
Large-scale testing (Phase 3)Study completedNCT03080415
What this trial is testing

Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir

Who this might be right for
Hepatitis C Genotype 4
Yassin Abdelghaffar Charity Center for Liver Disease and Research 40
Testing effectiveness (Phase 2)UnknownNCT01025297
What this trial is testing

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone

Who this might be right for
Hepatitis C
Cytheris SA 18
Large-scale testing (Phase 3)Study completedNCT01197157
What this trial is testing

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients

Who this might be right for
Hepatitis C
National Liver Institute, Egypt 200
Not applicableUnknownNCT01758939
What this trial is testing

Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients

Who this might be right for
Hepatitis C, Chronic
Cairo University 100,000
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Large-scale testing (Phase 3)Study completedNCT01838590
What this trial is testing

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 103
Post-approval studies (Phase 4)Study completedNCT00277862
What this trial is testing

Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4

Who this might be right for
Hepatitis C
Ain Shams University 280
Large-scale testing (Phase 3)Study completedNCT01006031
What this trial is testing

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Who this might be right for
Liver CirrhosisHepatitis C VirusHIV Infection
Sociedad Andaluza de Enfermedades Infecciosas 25
Large-scale testing (Phase 3)Study completedNCT02636595
What this trial is testing

The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)

Who this might be right for
Hepatitis C Virus
AbbVie 121
Testing effectiveness (Phase 2)Study completedNCT02350569
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 17
Large-scale testing (Phase 3)Study completedNCT00158496
What this trial is testing

Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

Who this might be right for
Chronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 100
Post-approval studies (Phase 4)Study completedNCT03111108
What this trial is testing

Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)

Who this might be right for
Hepatitis C Virus (HCV) Infection
Merck Sharp & Dohme LLC 117
Testing effectiveness (Phase 2)UnknownNCT00148837
What this trial is testing

Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

Who this might be right for
Hepatitis C, ChronicFibrosis
French National Agency for Research on AIDS and Viral Hepatitis 112
Not applicableStudy completedNCT01054742
What this trial is testing

Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 2
Load More Results